Press Releases Year None20232022202120202019 Dec 06, 2023 Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus Dec 06, 2023 Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus Nov 21, 2023 Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference Nov 09, 2023 Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates Nov 09, 2023 Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer Nov 09, 2023 Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases Nov 02, 2023 Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits at the 65th ASH Annual Meeting and Exposition Sep 26, 2023 Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference Aug 09, 2023 Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates May 11, 2023 Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Next page › Last page » Displaying 1 - 10 of 62
